| Fertility drug use and risk of ovarian tumors: a debated clinical challenge. | |
| | |
MedLine Citation:
|
PMID: 22946709 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Infertility itself increases the incidence of ovarian carcinoma, while the potential additional risk associated with the use of fertility drugs is still debated. In 1992, the cumulative analysis of 12 US case-control studies revealed that women who received ovulation-inducing drugs had approximately three-fold higher incidence of invasive ovarian carcinoma. Other investigations reported a lower increase of the risk of invasive carcinoma or borderline tumor of the ovary in women treated with these agents. Conversely, several other case-control or cohort studies failed to detect a significant correlation between fertility drug use and ovarian tumor risk in either parous or nulliparous women compared with untreated infertile women. Moreover neither the number of treatment cycles nor the type of drug used was associated with an increased risk in most studies. Incessant ovulation and excessive gonadotropin secretion have been long considered to play a major role in the development of ovarian carcinoma, and therefore fertility drugs, which raise the serum levels of gonadotropins and increase the chances of multiple ovulations, have been retained as a risk factor for this malignancy, However, the large majority of literature data as well as the new hypotheses on ovarian carcinogenesis appear to exclude a relevant impact of fertility drug use on the risk of ovarian tumors, and especially of high-grade invasive epithelial ovarian cancers. |
| | |
Authors:
|
Angiolo Gadducci; Maria Elena Guerrieri; Andrea Riccardo Genazzani |
Related Documents
:
|
22972109 - Skin preparation for preventing infection following caesarean section. 11964929 - Risk factors for febrile convulsions. 11552709 - Determinants of melanoma in a case-control study of twins (united states). 23355639 - Specialist clinics for reducing emergency admissions in patients with heart failure: a ... 22923669 - Effects of cardiovascular disease risk communication for patients with type 2 diabetes ... 23495789 - Remifentanil target-controlled infusion during second stage labour in high-risk parturi... 9315779 - Gonorrhea among men who have sex with men--selected sexually transmitted diseases clini... 15558299 - Radiographic outcomes among south african coal miners. 1820649 - Menstrual blood loss and iron nutrition in filipino women. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-9-5 |
Journal Detail:
|
Title: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology Volume: - ISSN: 1473-0766 ISO Abbreviation: Gynecol. Endocrinol. Publication Date: 2012 Sep |
Date Detail:
|
Created Date: 2012-9-5 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8807913 Medline TA: Gynecol Endocrinol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Procreative Medicine, Division of Gynecology and Obstetrics, University of Pisa , Pisa , Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Shotgun Lipidomics Strategy for Fast Analysis of Phospholipids in Fisheries Waste and Its Potential ...
Next Document: Cognitive function in patients with chronic pain treated with opioids: characteristics and associate...